DaxibotulinumtoxinA for Injection is an investigational agent being evaluated for therapeutic uses in muscle movement and pain disorders, two categories that have a range of available treatment options that do not offer long-term relief. Clinical trials are currently underway in cervical dystonia, adult upper limb spasticity and plantar fasciitis, with plans to study migraine.
